無料プレビュー

IQVIA Holdings Inc. (IQV) · New York Stock Exchange

プロフィール

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to life sciences and healthcare companies. The company offers technology platforms, real-world evidence solutions, analytics services, clinical trial support, laboratory services, and contract sales and medical engagement services. IQVIA operates through three reportable segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions, serving pharmaceutical, biotech, device, payer and provider customers across more than 100 count

主要指標

株価: $258.88 (+0.30%)
時価総額: 426億ドル
PER（今期予想）: 20.0
PBR: 7.0
配当利回り: —
52週レンジ: $154.50 – $277.40
業種: Healthcare / Medical - Diagnostics & Research
上場: New York Stock Exchange
構成銘柄: S&P 500 0.06%

比較会社: TMO Thermo Fisher Scientific Inc.、DHR Danaher Corporation、NTRA Natera, Inc.、A Agilent Technologies, Inc.、VEEV Veeva Systems Inc.、WAT Waters Corporation、IDXX IDEXX Laboratories, Inc.、ILMN Illumina, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-27 · 更新: 2026-10-08